← Назад к работе
Работы, на которые ссылается эта работа
Работ: 69
Работа: The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko, Abhishek D. Garg, Agnieszka Kaczmarek +3
Обзорная статья2012Цитирований: 4ABIDetection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková +7
Обзорная статья2020Цитирований: 3ABISafety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer +27
Статья2012Цитирований: 3ABIPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Andreas D. Hartkopf, Florin‐Andrei Taran, Markus Wallwiener +4
Обзорная статья2016Цитирований: 3ABIUsing immunotherapy to boost the abscopal effect
Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld +3
Обзорная статья2018Цитирований: 3ABIL-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors
Kwangsoo Kim, Jae‐Ho Jeong, Daejin Lim +9
Статья2015Цитирований: 2ABIMitochondrial dysfunction and oxidative stress in heart disease
Jessica N. Peoples, Anita Saraf, Nasab Ghazal +2
Обзорная статья2019Цитирований: 2ABIReactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
Andromachi Kotsafti, Marco Scarpa, Ignazio Castagliuolo +1
Обзорная статья2020Цитирований: 2ABIAnti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
Jihane Boustani, Benoît Lecoester, Jérémy Baude +4
Обзорная статья2021Цитирований: 2ABI